RhinoCyte develops and commercializes autologous olfactory-derived stem cell therapies to treat spinal cord injury and neurodegenerative disorders.
Business Model:
Revenue: $0
Employees: 1-10
Address: 1044 E Chestnut St
City: Louisville
State: KY
Zip: 40204
Country: US
RhinoCyte develops and commercializes autologous olfactory-derived stem cell therapies to treat spinal cord injury and neurodegenerative disorders.
Contact Phone:
+15024104512
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2012 | Debt Financing | $525k | 10/2015 | Convertible Note | $250k | 8/2006 | Series A | 3 | $930k |
Kentucky Seed Capital Fund Keyhorse Capital (KSTC) Queen City Angels Kentucky Seed Capital Fund Keyhorse Capital (KSTC) Queen City Angels |
6/2014 | Equity | $750k | 10/2009 | Debt Financing | $1.1M | 11/2011 | Debt Financing | $1.1M | 7/2014 | Venture Round | $750k |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|